Patrick Forde, MBBCh, is the codirector, Division of Upper Aerodigestive Malignancies, and professor of oncology at Johns Hopkins Medicine.
Treatment Approaches for Early-Stage Lung Cancer
Patrick Forde, MBBCh offers an overview of current standard-of-care treatments as well as emerging immunotherapy options for treating early-stage, resectable non-small cell lung cancer.
Repotrectinib Shows Frontline Responses in ROS1+ Advanced NSCLC
Patrick Forde, MBBCh, discusses the results of the TRIDENT-1 trial that led to the approval of repotrectinib for patients with metastatic ROS1 positive NSCLC.